Forty-nine of 52 (94.2%) children with musculoskeletal infection (MSKI) were successfully treated with cefadroxil dosed at 30 mg/kg/day over a 10-year time period. Two failures were associated with poor medication adherence. Our study suggests that treatment of MSKI with cefadroxil offers acceptable outcomes. Confirmation through clinical trials is appropriate.

中文翻译：

---

头孢羟氨苄用于学术儿科医院的肌肉骨骼感染。

52 名肌肉骨骼感染 (MSKI) 儿童中有 49 名 (94.2%) 在 10 年的时间内成功地接受了 30 mg/kg/天的头孢羟氨苄治疗。两次失败与服药依从性差有关。我们的研究表明，使用头孢羟氨苄治疗 MSKI 可提供可接受的结果。通过临床试验确认是合适的。